Adult neural stem cells (NSCs) are believed to facilitate CNS repair and tissue regeneration. However, it is not yet clear how these cells are influenced when the cellular environment is modified during neurotrauma or neuroinflammatory conditions. In this study, we determine how different proinflammatory cytokines modulate the expression of TLR2 and TLR4 in NSCs and how these cells respond to TLR2 and TLR4 agonists. Primary cultures of neural stem/progenitor cells isolated from the subventricular zone of brains from adult Dark Agouti rats were exposed to 1) supernatants from activated macrophages; 2) proinflammatory cytokines IFN-␥, TNF-␣, or both; and 3) agonists for TLR2 and TLR4. Both TLR2 and TLR4 were expressed during basal conditions and their mRNA levels were further increased following cytokine exposure. TLR4 was up-regulated by IFN-␥ and this effect was reversed by TNF-␣. TLR2 expression was increased by supernatants from activated macrophages and by TNF-␣, which synergized with IFN-␥. TLR agonists induced the expression of TNF-␣ mRNA. Importantly, TNF-␣ could be translated into protein and released into the supernatants where it was quantified by cytokine ELISA. In conclusion, we demonstrate that NSCs constitutively express TLR2 and TLR4 and that their expression is increased as a consequence of exposure to proinflammatory mediators. Additionally, activation of these receptors can induce production of proinflammatory cytokines. These findings suggest that NSCs may be primed to participate in cytokine production during neuroinflammatory or traumatic conditions.
T he ability of adult neural stem cells (NSCs) 3 to respond to trauma to the CNS by migration and differentiation at the site of injury has been demonstrated in numerous studies in various disease models (1) (2) (3) (4) . However, the role of NSCs in neuroinflammatory lesions is not entirely clear. It has become evident during recent years that these cells are not only a source of newly generated cells but may also supply trophic support to cells in the damaged CNS (5, 6) . Moreover, in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), NSCs have immunomodulatory effects (7, 8) and are induced to express immune markers characteristic of APCs (9) . The focus of this project is to 1) investigate the expression of the TLR2 and TLR4 on NSC/progenitor cells, both under normal and inflammatory conditions and 2) monitor the effects of TLR2 and TLR4 activation in NSC/progenitor cells.
TLRs are pattern recognition receptors characteristic of immune cells and are crucial for inducing an immune response to pathogens. Interestingly, Toll was first described in Drosophila to be involved in neural development (10, 11) , and in mammals TLRs are involved in differentiation of different stem cell populations, such as hematopoietic stem cells (12) (13) (14) and mesenchymal stem cells (15) . There are 13 TLRs described in mice and 10 in humans, and the best-described TLRs are TLR2 and TLR4. TLR2 associates with either TLR1 (16) or TLR6 (17) and binds lipoproteins and lipopeptides. TLR4 binds to LPS (18, 19) . In addition, all receptors have endogenous ligands (20 -23) that are released from damaged tissues, and there is available evidence suggesting that TLR2 and TLR4 may be involved in the disease development during EAE and MS (24 -27) . Neuroinflammatory conditions, such as MS and EAE, are characterized by infiltration of immune cells into the CNS and production of proinflammatory agents such as NO, TNF-␣, and IFN-␥, which in turn contribute to destruction of CNS tissue. The most predominant location of the inflammatory lesions in MS is close to the regenerative area of the subventricular zone (SVZ) where NSCs reside. NSCs can therefore be directly influenced by the inflammatory process.
In this study, we demonstrate evidence for TLR2 and TLR4 expression on NSCs both in vitro and in vivo. The expression of these receptors was transcriptionally up-regulated as a consequence to inflammatory exposure. The expression of TLR2 and TLR4 was differentially affected by the two major proinflammatory cytokines evident in EAE and MS, TNF-␣ and IFN-␥. IFN-␥ favored induction of TLR4. TNF-␣ induced the expression of TLR2 and abrogated the inducing effect of IFN-␥ on TLR4 expression. Moreover, the expression of TLR2 was up-regulated following exposure to supernatants from activated macrophages. Most importantly, NSCs exposed to TLR2 and TLR4 agonists produced and released TNF-␣ protein. We thus demonstrate that during neuroinflammatory conditions NSCs are able to up-regulate their expression of TLR2 and TLR4 and respond to receptor activation through release of a proinflammatory cytokine.
Materials and Methods

NSC culture
NSCs were isolated from adult female Dark Agouti (DA) rats (Scanbur B&K), 7-to 8-wk-old, according to a protocol previously described by Johansson et al. (28) . For propagation, the cells were cultured in DMEM/ F12 containing B27 supplement, penicillin (100 U/ml), streptomycin (100 g/ml) (Life Technologies), epidermal growth factor (20 ng/ml; SigmaAldrich), and basic fibroblast growth factor (20 ng/ml; R&D Systems). The experiments were performed using single cell suspensions that were either used directly for flow cytometry analysis or seeded on poly-Dlysine (Sigma-Aldrich) and cultured with propagation medium with 20 ng/ml epidermal and basic fibroblast growth factors, and 8 g/ml heparin (Sigma-Aldrich) with or without cytokines or TLR agonists according to the respective experimental setup. All experiments were performed with cells that had undergone two passages.
Macrophage cell culture and preparation of supernatants
Femurs from DA rats 7-to 8-wk-old were collected, and the marrow was flushed out and dissociated through a 25-gauge needle according to Andersson et al. (29) . Cells from two femurs were pooled in a 175-cm 2 flask and cultured in DMEM supplemented with 20% FCS, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 g/ml streptomycin, 2 mM L-glutamine, and 2-ME (all reagents from Life Technologies) and 20% L929 cell line supernatant. In total, the cells were cultured for 10 days, the last 2 days without the L929 supplement. Cells were harvested using trypsin-EDTA (Life technologies) for 10 min at 37°C, washed, and replated at 2 or 1 ϫ 10 5 cells/ml. After 24 h, the cells were activated using 100 ng/ml LPS (Sigma-Aldrich) or 100 U/ml IFN-␥, a gift from Dr. P. H. van der Meide (Utrecht University, the Netherlands) for 16 h. The cells were washed twice with DMEM/F12 and cultured with stem cell medium in the absence of mitogens for further 96 h when the medium was collected, filtered, and stored at Ϫ20°C. The supernatants were diluted 1/1 (vol/vol) in fresh NSC medium with epidermal and basic fibroblast growth factors before applying them onto the NSC cultures.
Two different controls for the carry-over of stimulants were performed. The "medium control" was actually supernatant collected from a well without macrophages. The stimulants were added to the well and the medium was changed 16 h later as for the wells containing macrophages. After 96 h, the medium was collected, filtered, and added to the NSC cultures designated as medium controls. To further control for carry-over of LPS, the known inducer of the TLR2 expression, IFN, was used as the sole macrophage stimulant. This process was done to exclude that increased TLR2 expression was due to LPS contamination. The supernatant from IFN-stimulated macrophages was as affective in inducing the TLR2 expression as the one from IFN plus LPS-stimulated macrophages. All animal experiments were approved by the local ethics committee.
Total mRNA isolation and reverse transcription
Total mRNA was isolated using an RNeasy mini kit (Qiagen). Reverse transcription was performed with 10 l of total RNA, random hexamer primers (0.1 g/ml; Life Technologies), and Superscript Reverse Transcriptase (200 U; Life Technologies).
Real-time PCR
Primers were designed using Primer Express software (Applied BioSystems) (Table I ). For quantification of mRNA levels, the QuantiTect SYBR (Qiagen) green methodology was used according to the manufacturer's instructions. Amplification was performed using an IQ5 optical detection system (Bio-Rad). Relative mRNA quantities of the target genes and housekeeping genes were calculated using standard curves made for each primer pair. The standard curve was constructed of a 4-fold dilution series of pooled samples. For each individual sample the expression of the target gene was normalized using two housekeeping genes, ␤-actin and hprt.
Abs and other reagents
The Abs used for immunocytochemistry were: mouse anti-TLR4, 1:40, (Abcam), rabbit anti-Sox2 (Chemicon International), mouse IgG2a (DakoCytomation), rabbit IgG (R&D Systems), goat anti-mouse IgG Alexa Fluor 594 (Molecular Probes), goat anti-rabbit IgG Alexa Fluor 488 (Molecular Probes), and biotinylated rabbit anti-goat 1/200 (DakoCytomation). All other Abs were used at 1/100 dilutions. For flow cytometry the following Abs were used: goat anti-TLR2 (Santa Cruz Biotechnology), goat anti-TLR4 (Santa Cruz Biotechnology), goat IgG (Jackson ImmunoResearch Laboratories), donkey anti-goat Alexa Fluor 488 (Molecular Probes), mouse R-PE-conjugated anti-CD11b (Serotec) and IgG2a-negative control (Serotec), PE-conjugated hamster (IgG1) anti-rat/mouse TNF Ab, and PEconjugated hamster IgG1 (BD Biosciences).
The cytokines and the concentrations used were recombinant rat IFN-␥ (100 U/ml), a gift from Dr. P. H. van der Meide (Utrecht University, the Netherlands), and recombinant rat TNF-␣ (1 ng/ml; Sigma-Aldrich). The following TLR agonists were used: Pam3Cys (1 g/ml; EMC Microcollections), LPS from Escherichia coli O111:B4 strain (100 ng/ml; SigmaAldrich), ultrapure LPS from E. coli O111:B4 strain (100 ng/ml; SigmaAldrich), lipoteichoic acid (LTA; Sigma-Aldrich), and HMGB1 (high mobility group box chromosomal protein 1, 1 g/ml; partly purchased from Sigma-Aldrich and partly provided by H. Erlandsson-Harris), which was a gift from author Dr. H. Erlandsson-Harris (Karolinska Institutet, Stockholm, Sweden). The used concentrations were determined with titration experiments and by using other researchers' publications as guidelines.
Immunofluorescence
Cells grown on coated coverslips and fixed with 4% paraformaldehyde in PBS (Bie and Berntsen) were blocked in PBS/0.1% saponin/5% goat serum and incubated with primary Ab at 4°C overnight. For Sox2 immunostaining the fixed cells were first permeabilized with a buffer containing 20 mM HEPES (pH 7.4), 300 mM saccharose, 50 mM NaCl, 3 mM MgCl 2 , 0.5% (vol/vol) Triton X-100 for 3 min at 4°C (30) . Cells were then blocked and incubated with the primary Ab. After washing, the secondary Ab was applied for 1 h at 37°C. Labeled cells were visualized and photographed using a fluorescence microscope (Leica Microsystems). For visualizing all cells, the nuclei were counterstained with DAPI (4Ј,6-diamidino-2-phenylindole). Isotype-matched Abs were used to control the specificity of the primary Ab.
Preparation of tissue sections and immunohistochemistry
DA rats, 7-to 8-wk-old, were euthanized by injecting a lethal dose of Dormicum/Katalan and were immediately perfused with PBS and then icecold 4% paraformaldehyde in PBS. Brains were removed and postfixed for 3 h in the same solution and then kept in 15% sucrose in PBS for 3 days. Cryosections were cut on Leica 3500M cryostat and stored at Ϫ20°C. Before immunostaining, the sections were dried for 30 min and rehydrated in PBS for 10 min. The sections were blocked for 1 h at room temperature in PBS/0.3% Triton X-100/4% BSA/4 drops of avidin block solution per ml (Vector Laboratories). The primary Abs (TLR2 or TLR4, 1/100; Santa Cruz Biotechnology) diluted in PBS/0.3% Triton X-100/1% BSA and four drops of biotin block solution per ml (Vector Laboratories) was applied overnight at 4°C. Biotinylated secondary Ab, diluted (1/200) in blocking solution (without the avidin blocking solution), was applied and incubated 
at room temperature for 1 h. The ABC solution (Vector Laboratories) was applied after washing and incubated for 1 h at room temperature. The staining was visualized using a diaminobenzidine substrate kit for peroxidase (Vector Laboratories) for 5-6 min. The sections were counterstained with hematoxylin, washed in tap water, dehydrated in ethanol and mounted in DEPEX Mounting medium (VWR International). Image analysis of the sections was performed with a microscope from Leica Microsystems.
Flow cytometry and cell sorting
Single cell suspensions of NSC/progenitor cells were fixed for 30 min at 4°C using 1% paraformaldehyde in PBS. Unspecific binding was blocked with 5% rat serum/0.1% saponin in PBS for 20 min. After washing, the primary Ab was applied for 30 min and washed, and the fluorophoreconjugated secondary Ab was applied for an additional 30 min. The cells were analyzed using a FACSCalibur (BD Biosciences). The entire staining procedure was performed on ice.
For negative sorting of CD11b ϩ cells, the neural spheres were dissociated 24 h before sorting and cultured in propagation medium. The following day the cells were washed, blocked in 5% rat serum in PBS, and stained with CD11b Ab and respective isotype control (10 l/million cells). The cells were then sorted using a MoFlow high-speed cell sorter (DakoCytomation).
TNF-␣ intracellular FACS staining
NSC/progenitor cells were seeded on poly-D-lysine-coated plates and stimulated for 48 -96 h with 1 g/ml Pam3Cys (EMC Microcollections). When 5-8 h of the stimulation time remained, brefeldin (BD GolgiPlug; BD Biosciences) was added to the cultures, 1 l/ml culture medium. The cells were harvested using prewarmed 100 g/ml Liberase Blendzyme 1 (Roche Diagnostics) in PBS. Subsequent fixation, blocking and staining steps were performed according to the BD Cytofix/Cytoperm Plus instruction manual (BD Biosciences). The PE-conjugated hamster (IgG1) anti-rat/mouse TNF Ab and matching isotype control were also purchased from BD Biosciences. To further control the staining specificity, a ligand-blocking control was performed by preincubating the TNF-specific Ab with rat TNF-␣ protein (Sigma-Aldrich).
TNF-␣ ELISA
Supernatants were collected from NSC/progenitor cell cultures 48 and 96 h after stimulation with TLR agonists, centrifuged, and frozen at Ϫ20°C. TNF-␣ was measured using the Quantikine ELISA kit from R&D Systems.
Proliferation assay
NSC/progenitor cells were seeded on 96-well U-bottom plates in triplicates 50,000 cells/well in 200 l of culture medium with or without epidermal and basic fibroblast growth factors. The cells were exposed to TLR agonists for 48 h before pulsing with [ 3 H]thymidine (1 Ci/well) for 24 h. Cells were harvested using a Tomtec cell harvester (Wallac Oy). The incorporated radioactivity was measured on a beta-liquid scintillation counter (1450 Microbeta Plus; Wallac Oy). The proliferation index was calculated by dividing the mean value of the cpm of the stimulated wells to the mean value of the unstimulated wells.
Statistics
For the experiment shown in Fig. 2A , the Mann-Whitney U test was performed. For calculating the correlation between TNF-␣ protein levels in the different macrophage supernatants used and the TLR2 expression they induced, we performed the Spearman correlation test (see Fig. 2D ). In the experiments for Figs. 3 and 4E, Wilcoxon signed ranked test was used. The experiments shown in Fig. 4 , A-C, used the ANOVA mixed model because we had two variables, stimuli and time. The stimuli-time interaction was also included in the model. The different stimuli observations at a certain time point were considered as dependent observations because the cells used originated from the same "mother-culture". Due to shortage in cell numbers, we could not follow the same experiment during all the time points. Thus, observations between time points were treated as independent observations. The increase in TLR2 expression induced by Pam3Cys was statistically significant ( p Ͻ 0.05; see Fig. 4A ). None of the stimuli were significant in the experiment shown in Fig. 4B . The increased expression induced by Pam3Cys was significant ( p Ͻ 0.05) and the LPS group had a tendency toward significance ( p ϭ 0.078) (see Fig. 4C ). The stimuli-time interaction was not statistically significant (see Fig. 4, A-C) . The unpaired t test was performed and the p values were the following: 48 h, unstimulated vs LPS, p ϭ 0.0229; unstimulated vs Pam3Cys, p ϭ 0.0468; 96 h, unstimulated vs LPS, p ϭ 0.0008; unstimulated vs Pam3Cys, p ϭ 0.0590 (see Fig. 4F ). When nothing else is stated, the reference group for statistical calculation was the untreated control group.
Results
NSC/progenitor cells express TLR2 and TLR4 in vitro and in vivo
To investigate whether NSC/progenitor cell cultures express TLR2 and TLR4, we performed flow cytometry and immunocytochemical analyses of NSC cultures after the second in vitro culture passage. Flow cytometry analysis revealed that NSC/progenitor cells express both TLR2 and TLR4, as depicted in Fig. 1, A and B , respectively. We also demonstrated that the TLR-expressing cells were positive for Sox2, a transcription factor involved in retaining the stem cells in an immature state (Fig. 1C) . By comparing with the DAPI-labeled nuclei in Fig. 1D , we estimated that more than 99% of the cells were double-labeled for Sox2 and TLR4, proving the homogeneity of these cultures with respect to TLR expression.
To elucidate whether the expression of the TLRs also occurred in vivo, we performed immunohistochemistry on brain sections from adult DA rats. As depicted in Fig. 1 , E-H, positive TLR2 (Fig. 1G) and TLR4 (Fig. 1H) immunolabeling could be detected in the ependymal and subependymal layers of the lateral ventricle, these regions containing NSC/progenitor cells (28, 31, 32) . Special focus was afforded to the lateral wall, embossed and enlarged in Fig. 1 , F-H, because this particular region was used for preparation of the in vitro NSC cultures.
Inflammatory conditions up-regulate TLR2 and TLR4 expression in NSC/progenitor cells
To investigate whether the expression of the TLR2 and TLR4 on the NSC/progenitor cells was altered during inflammatory conditions, NSCs were exposed to supernatant from activated macrophage cultures or the cytokines TNF-␣ or IFN-␥. First, NSC/progenitor cells were exposed to supernatants from activated macrophages (supernatant/culture medium; 1/1), which induced the TLR2 expression ( Fig. 2A) . In contrast, the TLR4 expression was not altered (Fig. 2A) . We then investigated whether the level of activation of the different macrophage cultures used for supernatant cytokine enrichment influenced the degree of TLR2 up-regulation on the NSCs. To measure macrophage activation we quantified the levels of TNF-␣ present in the supernatants and plotted these values against the expression values for TLR2 for each individual supernatant. There was a positive correlation ( p ϭ 0.0011, r 2 ϭ 0.8909) between the level of TLR2 increase on NSCs and the amount of TNF-␣ present in the different macrophage supernatants used (Fig. 2B) . Because blockade of TNF-␣ in the supernatants did not abrogate the elevation of the TLR2 expression, other cytokines released from the macrophages could account for the TLR2 up-regulation.
IFN-␥ and TNF-␣ differentially affect the expression of TLR2 and TLR4 on NSC/progenitor cells
The NSC/progenitor cell cultures were exposed to the two cytokines predominating during neuroinflammation, TNF-␣ and IFN-␥. We report that TLR2 expression was induced by IFN-␥ ( p Ͻ 0.05), TNF-␣ ( p Ͻ 0.05), and synergistically by both cytokines ( p Ͻ 0.05) (Fig. 3A) . In contrast, TLR4 was only induced by IFN-␥ ( p Ͻ 0.05) and the effect was abrogated by the addition of TNF-␣ (Fig. 3B ). (Fig. 3C) . To exclude that the CD11b ϩ cells were responsible for the results described so far, we measured TLR expression in sorted CD11b
Microglia were not responsible for the observed up-regulation of TLRs in NSC/progenitor cell cultures
Ϫ cultures following exposure to IFN-␥ and TNF-␣. As evident in Fig. 3, D and E, the pattern of TLR2 and TLR4 expression was similar in cultures devoid of CD11b cells as in nonsorted cultures.
TLR2 and TLR4 agonists induce TNF-␣ protein production from NSC/progenitor cells
To study the role of TLR2 and TLR4 receptor activation in NSC/ progenitor cell function we cultured the cells with the following TLR agonists: LTA, Pam3Cys, LPS, and HMGB1. LTA engages the heterodimer TLR2/TLR6, Pam3Cys ligates the TLR2/TLR1 heterodimer, whereas LPS binds to TLR4. HMGB1, an endogenous ligand for both TLR2 and TLR4 (20, 21) , is a DNA binding protein released by dying cells or activated macrophages and microglia. We investigated the effects of these TLR agonists on NSC/ progenitor cell TLR expression, cytokine production, proliferation and differentiation. We demonstrate that Pam3Cys significantly induced its own receptor expression, that of TLR2 ( p Ͻ 0.05) (Fig.  4A ), but the level of TLR4 expression was not influenced by any of the agonists (Fig. 4B) . Moreover, we observed that TNF mRNA was induced by all agonists of which Pam3Cys-dependent induction was statistically significant ( p Ͻ 0.05) (Fig. 4C) . TNF expression could also be induced in CD11b-depleted NSC cultures (see supplemental Fig. 3) . 4 Intracellular FACS staining (Fig.  4D) revealed that both unstimulated and stimulated NSC cultures had stores of intracellular TNF-␣; however, the amount of this cytokine was significantly increased ( p Ͻ 0.05) following stimulation with Pam3Cys (Fig. 4E) . In addition, TNF-␣ was only released in the supernatants after stimulation with LPS ( p Ͻ 0.05) or Pam3Cys ( p Ͻ 0.0008) and not from unstimulated cultures (Fig. 4F) . 4 The online version of this article contains supplemental material.
FIGURE 2.
Supernatants from activated macrophages regulate the expression of TLR2 on NSCs. A, TLR expression after 48 h of exposure to macrophage supernatant (n ϭ 4 different supernatants). The macrophage supernatant was collected from IFN (100 U/ml) and LPS (100 ng/ml) stimulated macrophage cultures (stim) or unstimulated cultures (unstim). Stim 1 ϭ 1 ϫ 10 5 and stim 2 ϭ 2 ϫ 10 5 macrophages/ml. B, Correlation between supernatant TNF-␣ and levels of TLR2 induced on NSCs. Data represent mean Ϯ SEM. r, correlation coefficient, for Spearman's correlation test. With the exception of the differentiation studies, the culture medium was always supplemented with mitogens. This step was to ensure that the data was acquired from undifferentiated NSC cultures, as demonstrated by anti-Sox2 immunostainings (see supplemental Fig. 5 ).
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TLR2 and TLR4 agonists do not effect NSC/progenitor cell proliferation or differentiation
In contrast to previously published data (34) neither TLR2 or TLR4 agonists influenced NSC/progenitor cell proliferation (Fig.  5A) or differentiation (Fig. 5B) as indicated by unaltered expression of the neuronal marker ␤III-tubulin or the astrocytic marker glial fibrillary acidic protein (GFAP). Even when TLR expression was boosted with IFN-␥, the presence of agonists did not further increase the expression of ␤III-tubulin or GFAP (Fig. 5C) . Furthermore, we performed immunostainings for ␤III-tubulin and GFAP 5 days poststimulation with Pam3Cys or LPS. No ␤III-tubulin was detected in any of the cultures, whereas GFAP was detected at equal levels in both stimulated and unstimulated cultures, supporting the previous results of no agonist-dependent differentiation (see supplemental Fig. 4 ). 4 Overall these results suggest that neither TLR2 nor TLR4 are involved in NSC/progenitor cell proliferation or differentiation, but that the cells are directed toward cytokine production and may thus contribute to the inflammatory process.
Discussion
The aim of the current study was to investigate whether adult NSC/ progenitors express TLR2 and TLR4 and how the expression of these receptors was modulated during inflammatory conditions. The rationale for studying TLR in NSCs was inspired from studies of Drosophila in which Toll, a TLR homolog, is involved in dorsoventral patterning of the fruit fly nervous system (10, 11) . The reason for choosing TLR2 and TLR4 for study is that both receptors have been analyzed extensively in the context of neuroinflammation, where an increased expression has been observed in the CNS of patients with MS (26, 27) and animals with EAE (24, 25) , implying that these receptors might be involved in the etiology of these diseases. We thus asked whether NSC/progenitor cells express TLR2 and TLR4 and if so, what the outcome is of TLR activation in NSCs.
We have evidence of NSC/progenitor cell expression of TLR2 and TLR4. Moreover, two important cytokines produced in inflammation, TNF-␣ and IFN-␥, differentially affect the expression of TLR2 and TLR4. Most importantly, receptor activation by recognition of their ligands clearly induces cytokine production in the NSC/progenitor cell cultures.
At what point do NSCs express TLR and what is the involvement of these receptors in NSC differentiation and proliferation?
During inflammatory conditions NSC/progenitor cells have been reported to express the costimulatory molecules B7-1 and B7-2, usually expressed on innate immune cells (9) . In contrast, we demonstrate that TLR are constitutively expressed in NSC/progenitor cells during normal conditions. In this aspect our results were supported by a recent publication by Rolls et al. (34) reporting TLR2 and TLR4 expression in cultures of NSCs and in the SVZ of adult mice. In contrast to our findings, it was reported that TLR2 and TLR4 had different effects on NSC proliferation and differentiation. We do not find induction or reduction of differentiation or proliferation in response to TLR2 or TLR4 agonists. The discrepancy of these results can have several explanations, including the use of different animal species. In the current study TLR agonists did not induce any increase of the mRNA or protein levels of the neuronal protein ␤III-tubulin or the astrocytic protein GFAP. Moreover, we also monitored agonist-induced NSC differentiation after boosting the expression of the TLR using IFN-␥. We report that IFN-␥ elevated the transcription of the neuronal marker ␤III-tubulin, the neurogenicity of which has been proven by other studies (35, 36) . No further change was detected upon addition of the TLR agonists.
How does inflammation regulate TLR expression?
In innate immune reactions TLRs recognize either microbial and viral molecules or endogenous danger molecules (such as HMGB1) released by damaged tissues. We first examined how the inflammatory milieu, mimicked by supernatants from classically activated macrophages, affected TLR2 and TLR4 expression by NSC/progenitor cells. We report that supernatants from macrophages elevated the expression of TLR2. This receptor was also up-regulated by exposure to either IFN-␥ or TNF-␣ alone and also synergistically by both. In contrast, the expression of TLR4 was only induced by IFN-␥, this effect being counteracted by TNF-␣.
Studies performed with various immune cells (37) have revealed that the extent of expression induction of the TLRs depends on the basal expression level of these receptors. Of the two receptors, TLR4 is often more robustly expressed, especially on immune cells, and its expression is not in all cases induced by inflammatory factors. This observation has been shown in macrophage cultures by our study and other research (37 and see supplemental Fig. 1 ). 4 The positive effect of IFN-␥ on TLR4 expression has been demonstrated in various cell types (38 -41) . The explanation for the TNF-␣ suppressive effect on TLR4 expression can in part be compared with the phenomenon of "endotoxin tolerance", in which TNF-␣ is part of a negative feedback loop down-regulating TLR4 signaling (42) (43) (44) . There is also evidence for direct TNF-␣ downregulation of TLR4 expression in human monocytes (44) but also for its up-regulating effects of TLR2 expression in microglia and astrocytes (45, 46) . These reports coincide with our data, wherein TNF-␣ up-regulated TLR2 and suppressed TLR4 induction. TNF-␣, but not IFN-␥ (or to a minimal extent) are present in macrophage supernatants and could account for the induced expression of TLR2 and the absent induction of TLR4. Moreover, blockage of TNF-␣ with a specific Ab could not abrogate the positive effect of the supernatant on TLR2 expression. This indicates the potential involvement of other cytokines such as IL-1␤. Finally, neither TNF-␣ nor IFN-␥ affected the expression of TLR9 (see supplemental Fig. 2 ), 4 suggesting a more specific effect on the expression of specific receptors and not a general effect on all TLRs.
What is the effect of TLR activation on NSCs?
Most importantly, we determined that NSCs produced TNF-␣ in response to TLR2 and TLR4 agonists, proving the functionality of these receptors in these cells. Others have also demonstrated transcription of different cytokine genes in NSCs (47), but not as a result of TLR activation. Most importantly, we detected intracellular TNF-␣ in unstimulated cultures. Even if this phenomenon would appear to be only an in vitro artifact, we stress that it should be taken into consideration from a transplantation viewpoint, in which usual routine involves an in vitro cell propagation step preceding the transplantation itself. Agonist stimulation leads to the release of TNF-␣, which is also accompanied by an elevation of TNF mRNA. This implies a de novo TNF production and not merely an emptying of intracellular stores.
In summary, in this study we demonstrate that NSC/progenitor cells from the SVZ of adult rats express TLR2 and TLR4 at mRNA and protein levels, both in vitro and in vivo. Moreover, engagement of the TLRs induced release of TNF-␣. The effects of TNF-␣ in the CNS are of dual outcome, inducing apoptosis and subsequent tissue damage (48, 49) , but may also be of benefit for remyelination through induction of differentiation of oligodendrocyte progenitor cells (50) .
In conclusion, NSCs constitutively express TLR2 and TLR4 and can be induced to respond to inflammation through activation of these receptors. Moreover, this activation enables release of a proinflammatory cytokines, which is of clinical relevance for understanding the etiology of neuroinflammatory conditions.
